Historic Release: GovInfo.gov Unveils the 2025 Edition of Title 21, Volume 4 of the Code of Federal Regulations
Washington D.C. – In a significant development for those who rely on timely and accessible federal regulations, GovInfo.gov, the official online repository for United States government publications, has officially released the 2025 annual edition of the Code of Federal Regulations (CFR), specifically Title 21, Volume 4. The publication, marked with a release date of August 20, 2025, at 2:23 PM, signifies the ongoing commitment to providing the public with comprehensive and up-to-date legal information.
The Code of Federal Regulations is the codification of the general and permanent rules and regulations published in the Federal Register by the executive departments and agencies of the Federal Government. Title 21, in particular, is a crucial section of the CFR, covering Food and Drugs, a broad and vital area encompassing the regulations administered by the Food and Drug Administration (FDA) and other related agencies.
Volume 4 of Title 21 delves into specific aspects of food and drug regulation, offering detailed guidance on a range of critical topics. While the specific contents are best reviewed directly on GovInfo.gov, this volume typically addresses regulations related to areas such as:
- Food Safety and Standards: This often includes regulations concerning the definition and standards of identity for various food products, labeling requirements, food additives, and preventive controls to ensure the safety and wholesomeness of food for consumption.
- Drug Regulation and Approval: This crucial segment likely outlines the rigorous processes for the development, testing, and approval of new drugs, including requirements for clinical trials, manufacturing practices (Current Good Manufacturing Practices – CGMPs), and post-market surveillance.
- Cosmetics and Medical Devices: Depending on the specific breakdown within Volume 4, it may also contain regulations pertaining to the safety, labeling, and marketing of cosmetics and medical devices, ensuring consumer protection across a wider spectrum of health-related products.
The timely release of the 2025 edition of Title 21, Volume 4, on GovInfo.gov underscores the platform’s role as a primary source for legal and regulatory information. This updated volume is an invaluable resource for a diverse audience, including:
- Industry Professionals: Manufacturers, distributors, and marketers within the food, drug, cosmetic, and medical device sectors will find essential guidance for compliance with federal mandates.
- Legal Practitioners: Attorneys specializing in administrative law, healthcare law, and food and drug law will utilize this resource for case preparation and client advisement.
- Researchers and Academics: Scholars and students studying public health, regulatory affairs, and related fields will benefit from the authoritative text of these regulations.
- Public Interest Advocates: Organizations and individuals dedicated to consumer safety and public health will find the details necessary to understand and advocate for regulatory standards.
The accessibility of these regulations through GovInfo.gov is paramount for fostering transparency and ensuring that all stakeholders can engage with the framework governing the nation’s food and drug supply. The platform’s commitment to providing the most current information empowers individuals and organizations to navigate the complexities of federal law with confidence.
To access the full text of the 2025 edition of Title 21, Volume 4, of the Code of Federal Regulations, interested parties are encouraged to visit GovInfo.gov. This release is a testament to the ongoing efforts to make government information readily available and understandable to all.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
govinfo.gov Code of FederalRegulations (Annual Edition) published ‘CFR-2025-title21-vol4’ at 2025-08-20 14:23. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.